Stock Trend Analysis Report
Prepared for you on Wednesday, December 1, 2021.
Loncar Cancer Immunotherapy ETF (NASDAQ:CNCR)
Long-Term Downtrend (-90) - CNCR is in a strong downtrend that is likely to continue. While CNCR is showing intraday strength, it remains in the confines of a bearish trend. Traders should use caution and set stops.
Is it time to buy, sell, or avoid CNCR?
MarketClub looks at technical strength and momentum to determine if the timing is right for CNCR.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
MarketClub’s Trade Triangles for CNCR
The long-term trend has been DOWN since Aug 17th, 2021 at 28.12
The intermediate-term trend has been DOWN since Nov 16th, 2021 at 28.45
The short-term trend has been DOWN since Nov 5th, 2021 at 29.55
Smart Scan Analysis for CNCR
Based on our trend formula, CNCR is rated as a -90 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
|Year High||32.32||Year High Date||2018-03-13|
|Year Low||19.1252||Year Low Date||2018-10-29|
|52wk High||35.818||52wk High Date||2021-02-08|
|52wk Low||26.555||52wk Low Date||2021-11-30|
|Average Volume||4,908||Shares Outstanding||100|